Suicidal Ideation and Suicide Attempts Among Middle-Aged and Older Patients With Schizophrenia Spectrum Disorders and Concurrent Subsyndromal Depression

2008 ◽  
Vol 196 (12) ◽  
pp. 884-890 ◽  
Author(s):  
Lori P. Montross ◽  
John Kasckow ◽  
Shahrokh Golshan ◽  
Ellen Solorzano ◽  
David Lehman ◽  
...  
Author(s):  
Matteo Balestrieri ◽  
Paola Rucci ◽  
Davide Amendola ◽  
Miki Bonizzoni ◽  
Giancarlo Cerveri ◽  
...  

Abstract Aims To analyse the hospital emergency department (HED) consultations for schizophrenia-spectrum disorders in nine Italian hospitals during the 2020 lockdown and post-lockdown periods, compared to the equivalent periods in 2019. Methods Characteristics of consultations, patients, and drug prescriptions were analysed. Joinpoint models were used to identify changes in the weekly trend of consultations. Results During the 2020 lockdown the overall number of HED consultations for schizophrenia decreased by 40.7% and after the lockdown by 12.2% compared with 2019. No difference was found in the proportion of consultations that led to GHPU admissions or compulsory admissions. Suicidality rates did not differ across the two years, with the exception of ideations and plans (+5.9%) during the post-lockdown period. We found an increase in benzodiazepine prescriptions in 2020 during the lockdown and post-lockdown periods (+10.6% and +20.8%, respectively), and a decrease of prescriptions for short-acting sedative agents in the post-lockdown period (-7.9%). An increase in the weekly trend of consultations occurred from March 11-17 (week 11) to June 26-June 30 (week 26). As a result, the initial gap in the number of consultations between the two years cancelled out at the end of June. Conclusions HED consultation rate for schizophrenia-spectrum disorders declined consistent with that of other psychiatric disorders. In the post-lockdown period the growth of suicidal ideation/planning and increase in the prescriptions of anxiolytic-sedating drugs may foreshadow that for some schizophrenia patients the exit from the lockdown period is not liberating, but rather a source of agitation or perturbation.


2015 ◽  
Vol 230 (2) ◽  
pp. 728-731 ◽  
Author(s):  
Gábor Gazdag ◽  
Emese Belán ◽  
Ferenc A Szabó ◽  
Gabor S Ungvari ◽  
Pál Czobor ◽  
...  

2015 ◽  
Vol 228 (3) ◽  
pp. 791-796 ◽  
Author(s):  
Juan A. Gallego ◽  
Vivekananda Rachamallu ◽  
Eunice Y. Yuen ◽  
Sabina Fink ◽  
Laura M. Duque ◽  
...  

2017 ◽  
Vol 62 (10) ◽  
pp. 726-734 ◽  
Author(s):  
Emmanuel Stip ◽  
Jean Caron ◽  
Michel Tousignant ◽  
Yves Lecomte

Objective: To predict suicidal ideation in people with schizophrenia, certain studies have measured its relationship with the variables of defeat and entrapment. The relationships are positive, but their interactions remain undefined. To further their understanding, this research sought to measure the relationship between suicidal ideation with the variables of loss, entrapment, and humiliation. Method: The convenience sample included 30 patients with schizophrenia spectrum disorders. The study was prospective (3 measurement times) during a 6-month period. Results were analyzed by stepwise multiple regression. Results: The contribution of the 3 variables to the variance of suicidal ideation was not significant at any of the 3 times (T1: 16.2%, P = 0.056; T2: 19.9%, P = 0.117; T3: 11.2%, P = 0.109). Further analyses measured the relationship between the variables of stigmatization, perceived cognitive dysfunction, symptoms, depression, self-esteem, reason to live, spirituality, social provision, and suicidal ideation. Stepwise multiple regression demonstrated that the contribution of the variables of stigmatization and perceived cognitive dysfunction to the variance of suicidal ideation was significant at all 3 times (T1: 41.7.5%, P = 0.000; T2: 35.2%, P = 0.001; T3: 21.5%, P = 0.012). Yet, over time, the individual contribution of the variables changed: T1, stigmatization (β = 0.518; P = 0.002); T2, stigmatization (β = 0.394; P = 0.025) and perceived cognitive dysfunction (β = 0.349; P = 0.046). Then, at T3, only perceived cognitive dysfunction contributed significantly to suicidal ideation (β = 0.438; P = 0.016). Conclusion: The results highlight the importance of the contribution of the variables of perceived cognitive dysfunction and stigmatization in the onset of suicidal ideation in people with schizophrenia spectrum disorders.


2015 ◽  
Vol 30 (7) ◽  
pp. 830-836 ◽  
Author(s):  
E. Kjelby ◽  
I. Sinkeviciute ◽  
R. Gjestad ◽  
R.A. Kroken ◽  
E.-M. Løberg ◽  
...  

AbstractBackground:Assessment of suicide risk is crucial in schizophrenia and results concerning risk contributed by hallucinations and persecutory delusions are inconsistent. We aimed to determine factors associated with suicidal ideation and plans at the time of acute admission in patients suffering from schizophrenia spectrum disorders.Methods:One hundred and twenty-four patients older than 18 years admitted to an acute psychiatric ward due to psychosis were consecutively included. Predictors of suicidal ideation and suicide plans at the time of admission were examined with multinominal logistic regression and structural equation modelling (SEM). The study design was pragmatic, thus entailing a clinically relevant representation.Results:Depression Odds Ratio (OR) 12.9, Drug use OR 4.07, Hallucinations OR 2.55 and Negative symptoms OR 0.88 significantly predicted Suicidal ideation. Suspiciousness/ Persecution did not. Only Depression and Hallucinations significantly predicted Suicide plans. In the SEM-model Anxiety, Depression and Hopelessness connected Suspiciousness/Persecution, Hallucinations and Lack of insight with Suicidal ideation and Suicide plans.Conclusions:The study contributes to an increasing evidence base supporting an association between hallucinations and suicide risk. We want to emphasise the importance of treating depression and hallucinations in psychotic disorders, reducing hopelessness while working with insight and reducing drug abuse in order to lower suicide risk.Trial registration:ClinicalTrials.gov ID; URL: http://www.clinicaltrials.gov/NCT00932529.


Healthcare ◽  
2021 ◽  
Vol 9 (4) ◽  
pp. 389
Author(s):  
Ahmed Hassan ◽  
Vincenzo De Luca ◽  
Nasia Dai ◽  
Alessio Asmundo ◽  
Nunzio Di Nunno ◽  
...  

Background: The aim of this study is to evaluate whether any specific antipsychotic regimen or dosage is effective in managing suicidal ideation in schizophrenia. Four comparisons were conducted between: (1) clozapine and other antipsychotics; (2) long-acting injectable and oral antipsychotics; (3) atypical and typical antipsychotics; (4) antipsychotics augmented with antidepressants and antipsychotic treatment without antidepressant augmentation. Methods: We recruited 103 participants diagnosed with schizophrenia spectrum disorders. Participants were followed for at least six months. The Beck Scale for Suicidal Ideation (BSS) was used to assess the severity of suicidal ideation at each visit. We performed a multiple linear regression model controlling for BSS score at study entry and other confounding variables to predict the change in the BSS scores between two visits. Results: Overall, there were 28 subjects treated with clozapine (27.2%), and 21 subjects with depot antipsychotics (20.4%). In our sample, 30 subjects experienced some suicidal ideation at study entry. When considering the entire sample, there was a statistically significant decrease in suicidal ideation severity in the follow-up visit compared to the study entry visit (p = 0.043). Conclusions: To conclude, our preliminary analysis implies that antipsychotics are effective in controlling suicidal ideation in schizophrenia patients, but no difference was found among alternative antipsychotics’ classes or dosages.


2000 ◽  
Author(s):  
B. Cornblatt ◽  
M. Obuchowski ◽  
S. Roberts ◽  
S. Pollack ◽  
L. Erienmeyer-Kimling

Sign in / Sign up

Export Citation Format

Share Document